MyEClinic
MyEClinic
Health Dictionary Find a Doctor

RVD regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:Bortezomib/Dexamethasone/Lenalidomide Regimen; RVD; Velcade/Revlimid/Dexamethasone; VRD; VDR

Overview

RVD regimen refers to a treatment regimen consisting of a combination of revlimid (lenalidomide), velcade (bortezomib) and dexamethasone used in the treatment of multiple myeloma[1][2]

Regimen

RRevlimid (lenalidomide)

VVelcade (Bortezomib)

DDexamethasone

Indications

References

  1. ↑ 1.0 1.1 Nooka AK, Kaufman JL, Muppidi S, Langston A, Heffner LT, Gleason C; et al. (2014). “Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients”. Leukemia. 28 (3): 690–3. doi:10.1038/leu.2013.335. PMID 24220275.
  2. ↑ “NCI Thesaurus”.

Imprint

Privacy Policy

Terms and Conditions

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH